A tissue-engineered model of the blood-tumor barrier during metastatic breast cancer

Metastatic brain cancer has poor prognosis due to challenges in both detection and treatment. One contributor to poor prognosis is the blood–brain barrier (BBB), which severely limits the transport of therapeutic agents to intracranial tumors. During the development of brain metastases from primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Linville, Raleigh M., Maressa, Joanna, Guo, Zhaobin, Chung, Tracy D., Farrell, Alanna, Jha, Ria, Searson, Peter C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623725/
https://www.ncbi.nlm.nih.gov/pubmed/37924145
http://dx.doi.org/10.1186/s12987-023-00482-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623725/
https://www.ncbi.nlm.nih.gov/pubmed/37924145
http://dx.doi.org/10.1186/s12987-023-00482-9

Ejemplares similares